AbVitro, Inc. is a therapeutic target discovery company, with a unique technology platform that leverages natural immune responses to address diseases with unmet medical needs. Based on technology developed by the visionary George Church at Harvard Medical School, our technology allows for the identification of complete, natively paired B cell antibodies and T cell receptors […]![]()
